
Concert Pharma (CNCE) Earnings Dates & Reports
Concert Pharma (CNCE) Most Recent Earnings
Report DateNov 7, 2022
Period EndingQ3 2022
Est. EPS-$0.59
Actual EPS-$0.58
EarningsBeat
Concert Pharma (CNCE) Earnings
View the latest Concert Pharma (CNCE) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Concert Pharma (CNCE)
Order type
Buy in
Order amount
Est. shares
0 shares
Concert Pharma (CNCE) Earnings per Share (EPS) History
Signup for full accessBrowse free
Concert Pharma (CNCE) Latest Earnings
The value each CNCE share was expected to gain vs. the value each share gained.
Concert Pharma (CNCE) reported its most recent earnings on Nov 7, 2022 for Q3 2022, posting earnings per share (EPS) of -$0.58. This exceeded analysts' expectations of -$0.59 by 1.69%, marking a Beat.
For comparison, Concert Pharma reported EPS of -$0.78 in the same quarter last year.
The company is expected to announce its next earnings report on 11/07/2022, with analysts projecting an EPS of $0.
Concert Pharma (CNCE) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
|---|---|---|---|---|
Q3 2022Nov 7, 2022 | -$0.59 | -$0.58 | -1.69% | |
Q2 2022Aug 4, 2022 | -$0.89 | -$0.59 | -33.71% | |
Q1 2022May 5, 2022 | -$0.91 | -$1.03 | +13.19% | |
Q4 2021Mar 3, 2022 | -$0.73 | -$1.01 | +38.36% | |
Q3 2021Nov 9, 2021 | -$0.81 | -$0.78 | -3.70% | |
Concert Pharma (CNCE) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Concert Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| Aug 4, 2022 | — | — | — |
| May 5, 2022 | — | — | — |
| Mar 3, 2022 | — | — | — |
| Nov 9, 2021 | — | — | — |
Concert Pharma (CNCE) Earnings FAQs
Concert Pharma (CNCE) last reported earnings on Nov 7, 2022 for Q3 2022, posting an EPS of -$0.58, which Beat the estimate of -$0.59 by 1.69%.
For Q3 2022, Concert Pharma (CNCE) reported an EPS of -$0.58, exceeding analysts' estimate of -$0.59 by 1.69%.
For Q3 2022, Concert Pharma (CNCE) Beat expectations with an actual EPS of -$0.58 vs. an estimated EPS of -$0.59.
Following the last earnings report on Nov 7, 2022, Concert Pharma (CNCE)'s stock price moved — from — to —.
The next Concert Pharma (CNCE) earnings call is scheduled for Nov. 7, 2022, where executives will discuss financial results and outlook.